Emmaus Life Sciences EMMA
OTC EMMA
$0.06 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Emmaus Life Sciences (EMMA) Price to Earnings (2013 - 2020)

Updated

Emmaus Life Sciences' (EMMA) Price to Earnings came in at 44.50 for Q4 2020, up 432.3% from the prior quarter.

Analysis

Emmaus Life Sciences (EMMA) Price to Earnings (2013 - 2020) Analysis & Trends

Since Q2 2013, Emmaus Life Sciences has reported Price to Earnings for 5 quarters.

  • The Q4 2020 figure stands as the highest quarterly Price to Earnings since Q3 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Emmaus Life Sciences 4.21 Mn -2.09 Mn 5.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 44.50
Sep 30, 2020 8.36
Dec 31, 2018 0.89
Sep 30, 2018 53.27
Jun 30, 2013 280.32
Mar 31, 2013 3.85
API Access

Emmaus Life Sciences Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=EMMA&period=max&api_key=YOUR_API_KEY